3 Year Absolute Returns
97.83% ↑
NAV (₹) on 16 Apr 2026
493.63
1 Day NAV Change
0.06%
Risk Level
Very High Risk
Rating
-
SBI Healthcare Opportunities Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by SBI Funds Management Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP ... Read more
AUM
₹ 4,063.64 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 64.61% |
| Hospitals & Medical Services | 24.51% |
| Chemicals - Speciality | 4.19% |
| Treps/Reverse Repo | 3.36% |
| Foreign Securities | 2.97% |
| Medical Equipment & Accessories | 1.88% |
| Treasury Bill | 0.07% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.65% | ₹ 434.25 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 7.55% | ₹ 307.61 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.76% | ₹ 234.65 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 4.82% | ₹ 196.55 | Hospitals & Medical Services |
| Acutaas Chemicals Ltd. | 4.77% | ₹ 194.29 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 4.25% | ₹ 173.33 | Pharmaceuticals |
| Lupin Ltd. | 4.23% | ₹ 172.64 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 3.85% | ₹ 157.10 | Hospitals & Medical Services |
| Biocon Ltd. | 3.59% | ₹ 146.18 | Pharmaceuticals |
| Laurus Labs Ltd. | 3.48% | ₹ 142.01 | Pharmaceuticals |
| Aether Industries Ltd. | 3.29% | ₹ 134.20 | Chemicals - Speciality |
| Fortis Healthcare Ltd. | 3.24% | ₹ 131.97 | Hospitals & Medical Services |
| TREPS | 3.19% | ₹ 129.96 | Others |
| Lonza Group | 3.09% | ₹ 126.12 | Others |
| Mankind Pharma Ltd. | 2.98% | ₹ 121.37 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 2.92% | ₹ 119.21 | Hospitals & Medical Services |
| Jupiter Life Line Hospitals Ltd. | 2.79% | ₹ 113.56 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 2.77% | ₹ 112.79 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.68% | ₹ 109.33 | Pharmaceuticals |
| Anthem Biosciences Ltd. | 2.68% | ₹ 109.38 | Pharmaceuticals |
| Concord Biotech Ltd. | 2.16% | ₹ 87.88 | Pharmaceuticals |
| Sudeep Pharma Ltd. | 2.13% | ₹ 86.90 | Pharmaceuticals |
| Polymedicure Ltd. | 1.97% | ₹ 80.39 | Medical Equipment & Accessories |
| Sai Life Sciences Ltd. | 1.96% | ₹ 79.86 | Pharmaceuticals |
| Abbott India Ltd. | 1.95% | ₹ 79.59 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 1.84% | ₹ 74.85 | Pharmaceuticals |
| Nephrocare Health Service Pvt. Ltd. | 1.17% | ₹ 47.50 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 0.91% | ₹ 37.19 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd. | 0.83% | ₹ 33.67 | Chemicals - Speciality |
| Gufic Biosciences Ltd. | 0.69% | ₹ 28.19 | Pharmaceuticals |
| Medplus Health Services Ltd. | 0.62% | ₹ 25.43 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd. | 0.62% | ₹ 25.11 | Hospitals & Medical Services |
| Corona Remedies Ltd. | 0.39% | ₹ 15.87 | Pharmaceuticals |
| Pfizer Ltd. | 0.37% | ₹ 15.19 | Pharmaceuticals |
| 364 DAY T-BILL 19.11.26 | 0.07% | ₹ 2.89 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -2.20% | 5.51% | 12.79% | 25.53% |
| Category returns | -0.43% | 7.70% | 10.32% | 23.90% |
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
SBI Conservative Hybrid Fund
Hybrid
Regular
|
₹21.64 | 6.12% | 32.28% | 56.17% | ₹9,546 | 1.54% |
High
|
|
SBI Conservative Hybrid Fund
Hybrid
Regular
|
₹21.64 | 6.12% | 32.28% | 56.17% | ₹9,546 | 1.54% |
High
|
|
SBI Conservative Hybrid Fund - Div (Annual)
Hybrid
Regular
|
₹26.47 | 6.12% | 32.28% | 56.17% | ₹9,546 | 1.10% |
High
|
|
SBI Conservative Hybrid Fund - Div (Annual)
Hybrid
Regular
|
₹26.47 | 6.12% | 32.28% | 56.17% | ₹9,546 | 1.10% |
High
|
|
SBI Conservative Hybrid Fund
Hybrid
Regular
|
₹75.04 | 6.12% | 32.28% | 56.17% | ₹9,546 | 1.54% |
High
|
|
SBI Retirement Benefit Fund - Conservative Hybrid Plan -...
Hybrid
Direct
|
₹15.95 | 3.09% | 30.21% | 56.80% | ₹248 | 1.15% |
High
|
|
SBI Retirement Benefit Fund - Conservative Hybrid Plan -...
Hybrid
Direct
|
₹15.95 | 3.09% | 30.21% | 56.78% | ₹248 | 1.15% |
High
|
|
SBI Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,144.05 | 0.00% | 0.27% | 9.89% | ₹57,891 | 0.19% |
Low to Moderate
|
|
SBI Liquid Fund
Liquid
Regular
|
₹1,140.74 | 0.00% | 0.27% | 9.66% | ₹57,891 | 0.28% |
Low to Moderate
|
|
SBI Nifty Private Bank ETF
ETF
Regular
|
₹275.63 | 0.18% | 28.69% | 61.45% | ₹366 | 0.15% |
Very High
|
What is the current NAV of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What is the fund size (AUM) of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What are the historical returns of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What is the risk level of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What is the minimum investment amount for SBI Healthcare Opportunities Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article